Furthermore, we indicated that the expression level of UBE2C has altered in different pathological stages that positively correlated with cancer stage and the results showed higher expression of UBE2C in the late stages of cancer compared to early stages including ACC, BRCA, KICH, KIRC, KIRP, LIHC, LUAD, LUSC, PAAD, TGCT, and THCA. The gene discussed is UBE2C; the disease is cancer.